Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
October 11, 2018

Trades at 9x earnings. The Aetna deal with likely be approved soon, being a vertical integration in the healthcare sector. The only question is can they integrate successfully? (2.7%, Analysts' price target: $88.14)

Show full opinionHide full opinion
CVS Health Corp (CVS-N)
October 11, 2018

Trades at 9x earnings. The Aetna deal with likely be approved soon, being a vertical integration in the healthcare sector. The only question is can they integrate successfully? (2.7%, Analysts' price target: $88.14)

BUY
BUY
October 11, 2018

Short-seller Muddy Waters is about a specific legal case in progress. Strong franchise in Asia, but what's hurting them is their John Hancock franchise in the U.S. with a low ROE. Have a strong asset management business. MFC must deal with Hancock--can't sell it but must improve ROE. Management is slowly doing that. Now is a good buying opportunity with a good yield. Could take time.

Show full opinionHide full opinion
Manulife Financial (MFC-T)
October 11, 2018

Short-seller Muddy Waters is about a specific legal case in progress. Strong franchise in Asia, but what's hurting them is their John Hancock franchise in the U.S. with a low ROE. Have a strong asset management business. MFC must deal with Hancock--can't sell it but must improve ROE. Management is slowly doing that. Now is a good buying opportunity with a good yield. Could take time.

COMMENT
COMMENT
October 11, 2018

They make beautiful cars, but Musk has been inconsistent and are burning a lot of cash. Musk needs somebody who can actually run a car business. Musk is a visionary, but he needs to run a business, like Steve Jobs at Apple needed somebody. He will likely do an equity issue and dilute the stock. If Tesla keeps missing numbers, competitors will slowly catch up.

Show full opinionHide full opinion
Tesla Motors Inc (TSLA-Q)
October 11, 2018

They make beautiful cars, but Musk has been inconsistent and are burning a lot of cash. Musk needs somebody who can actually run a car business. Musk is a visionary, but he needs to run a business, like Steve Jobs at Apple needed somebody. He will likely do an equity issue and dilute the stock. If Tesla keeps missing numbers, competitors will slowly catch up.

COMMENT
COMMENT
October 11, 2018

A top investment bank in the world. New CEO needs to talk about the company more, but investment banks should do well in volatility. What's hurt Goldman is that its retail side if weak and are only now slowly going into that area and seeing decent growth. Beware: there's a lot of volatility in investment banking and they don't have retail to fall back on. A good brand to own.

Show full opinionHide full opinion
Goldman Sachs (GS-N)
October 11, 2018

A top investment bank in the world. New CEO needs to talk about the company more, but investment banks should do well in volatility. What's hurt Goldman is that its retail side if weak and are only now slowly going into that area and seeing decent growth. Beware: there's a lot of volatility in investment banking and they don't have retail to fall back on. A good brand to own.

COMMENT
COMMENT
October 11, 2018

Stock has come off when CEO Jack Ma left. A big issue is how they grow outside China--can they do it? Valuation isn't cheap, but they are strong in China along with a growing middle class. They will do well long-term there.

Show full opinionHide full opinion

Stock has come off when CEO Jack Ma left. A big issue is how they grow outside China--can they do it? Valuation isn't cheap, but they are strong in China along with a growing middle class. They will do well long-term there.

BUY
BUY
October 11, 2018

Great company. Pharma, medical devices and consumer are their 3 divisions, which makes them unique--that diversification serves them well, unlike phrama companies depend solely on their pharma division. Has raised dividend for 54 years. Well run.

Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
October 11, 2018

Great company. Pharma, medical devices and consumer are their 3 divisions, which makes them unique--that diversification serves them well, unlike phrama companies depend solely on their pharma division. Has raised dividend for 54 years. Well run.

COMMENT
COMMENT
October 11, 2018

Hard to value Netflix. They have pricing power and dominate the growing streaming sector. Good market share in the U.S. and growing share outside U.S. It's all about the content they produce, which eats up their cash flow. It'll be volatile. Young people who use Netflix share their passwords, so that's an issue. Netflix has to deal with this. But their brand is strong and the shift to streaming away from TV is definitely on their side.

Show full opinionHide full opinion
Netflix Inc. (NFLX-Q)
October 11, 2018

Hard to value Netflix. They have pricing power and dominate the growing streaming sector. Good market share in the U.S. and growing share outside U.S. It's all about the content they produce, which eats up their cash flow. It'll be volatile. Young people who use Netflix share their passwords, so that's an issue. Netflix has to deal with this. But their brand is strong and the shift to streaming away from TV is definitely on their side.